Brookfield Asset Management Inc. Nevro Corp Transaction History

Brookfield Asset Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$36.43 - $49.4 $364,810 - $494,691	10,014 New	10,014 $396,000
Q2 2022 Nov 16, 2022	BUY	$40.85 - $77.67 $310,664 - $590,680	7,605 New	7,605 $333,000
Q2 2022 Aug 15, 2022	SELL	$40.85 - $77.67 $31,372 - $59,650	-768 Reduced 9.17%	7,605 $333,000
Q1 2022 May 16, 2022	BUY	$59.95 - $92.06 $187,463 - $287,871	3,127 Added 59.61%	8,373 $605,000
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $21,564 - $32,263	266 Added 5.34%	5,246 $425,000
Q3 2021 Nov 16, 2021	SELL	$101.99 - $166.36 $479,862 - $782,723	-4,705 Reduced 48.58%	4,980 $579,000
Q2 2021 Aug 17, 2021	BUY	$141.6 - $179.06 $532,416 - $673,265	3,760 Added 63.46%	9,685 $1.61 Million
Q1 2021 May 17, 2021	BUY	$132.81 - $182.18 $786,899 - $1.08 Million	5,925 New	5,925 $826,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.